Pumpinheart

medical devices

About

Pumpinheart is a medical technology company that originated from the Royal College of Surgeons in Ireland. It focuses on creating an innovative heart pump designed to treat diastolic heart failure with preserved ejection fraction (HFpEF), a condition affecting millions of patients in North America and Europe. The company aims to provide interventional cardiologists with a new tool to enhance survival and quality of life for patients facing limited treatment options. The core product is a miniaturized, implantable heart pump that is delivered through a transfemoral transseptal approach. About the size of a AAA battery, this device is implanted into the left aorta to assist cardiac function in HFpEF patients. Pumpinheart is actively pursuing funding to support the development of this technology, with plans for clinical trials in the near future. Founded in 2022, the company operates from Galway and Dublin, Ireland, and targets healthcare providers managing advanced HFpEF patients.

Technologies

Amazon AWS Mobile Friendly WordPress.org Vimeo

Keywords

medical device regulatory approval implantable cardiac device heart failure therapy device transcutaneous energy transfer system medical device design pre-clinical research medical research awards heart failure device development medical devices interventional cardiology implantable medical device medical device regulation hfpef implant transcatheter device medical device commercialization medical device funding cardiology innovation implantable cardiac pump medical device clinical trials heart failure device research implantable diastolic pump medical device innovation awards diastolic pump heart failure device clinical trials medical device development ireland medtech startup medtech innovation heart failure with preserved ejection fraction medical device patent cardiology device

Location

Old Dublin Road, Galway, County Galway, Ireland, H91 DCH9

Related Companies

Companies in the same industry